133 related articles for article (PubMed ID: 31478931)
1. Dantrolene Should Be Readily Available Wherever Malignant Hyperthermia Triggering Drugs Are Stocked.
Larach MG; Riazi S; Rosenberg H
Anesth Analg; 2019 Nov; 129(5):e175-e176. PubMed ID: 31478931
[No Abstract] [Full Text] [Related]
2. Pennywise and a Pound Foolish: The Advantage of Dantrolene Nanosuspension (Ryanodex) in the Treatment of Malignant Hyperthermia.
McAvoy JC; Brodsky JB; Brock-Utne J
Anesth Analg; 2019 Dec; 129(6):e201-e202. PubMed ID: 31743207
[No Abstract] [Full Text] [Related]
3. Cost-benefit Analysis of Maintaining a Fully Stocked Malignant Hyperthermia Cart versus an Initial Dantrolene Treatment Dose for Maternity Units.
Ho PT; Carvalho B; Sun EC; Macario A; Riley ET
Anesthesiology; 2018 Aug; 129(2):249-259. PubMed ID: 29672336
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of stocking dantrolene in ambulatory surgery centers for the treatment of malignant hyperthermia.
Aderibigbe T; Lang BH; Rosenberg H; Chen Q; Li G
Anesthesiology; 2014 Jun; 120(6):1333-8. PubMed ID: 24714119
[TBL] [Abstract][Full Text] [Related]
5. Malignant Hyperthermia-Susceptible Adult Patient and Ambulatory Surgery Center: Society for Ambulatory Anesthesia and Ambulatory Surgical Care Committee of the American Society of Anesthesiologists Position Statement.
Urman RD; Rajan N; Belani K; Gayer S; Joshi GP
Anesth Analg; 2019 Aug; 129(2):347-349. PubMed ID: 31166228
[TBL] [Abstract][Full Text] [Related]
6. Malignant hyperthermia in an office surgery suite: a case report.
Turpin IM; Manino J
Aesthetic Plast Surg; 1989; 13(2):121-3. PubMed ID: 2741752
[TBL] [Abstract][Full Text] [Related]
7. [Stocks of dantrolene in anesthesia and intensive care units in Germany : Nationwide online survey with 1673 participants].
Pfenninger E; Heiderich S; Klingler W
Anaesthesist; 2017 Oct; 66(10):773-781. PubMed ID: 28660414
[TBL] [Abstract][Full Text] [Related]
8. In Response.
Urman RD; Rajan N; Belani K; Gayer S; Joshi GP
Anesth Analg; 2019 Dec; 129(6):e202. PubMed ID: 31743208
[No Abstract] [Full Text] [Related]
9. [Treatment of malignant hyperthermia crisis during anesthesia].
Amiel I; Nivoche Y
Ann Fr Anesth Reanim; 1989; 8(5):427-34. PubMed ID: 2697157
[TBL] [Abstract][Full Text] [Related]
10. Special article: Creation of a guide for the transfer of care of the malignant hyperthermia patient from ambulatory surgery centers to receiving hospital facilities.
Larach MG; Dirksen SJ; Belani KG; Brandom BW; Metz KM; Policastro MA; Rosenberg H; Valedon A; Watson CB; ; ; ; ;
Anesth Analg; 2012 Jan; 114(1):94-100. PubMed ID: 22052978
[TBL] [Abstract][Full Text] [Related]
11. Malignant hyperthermia in the ambulatory surgery center: how should we prepare?
Litman RS; Joshi GP
Anesthesiology; 2014 Jun; 120(6):1306-8. PubMed ID: 24710219
[No Abstract] [Full Text] [Related]
12. Malignant hyperthermia.
Ben Abraham R; Adnet P; Glauber V; Perel A
Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
[TBL] [Abstract][Full Text] [Related]
13. Consensus Statement of the Malignant Hyperthermia Association of the United States on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia.
Litman RS; Smith VI; Larach MG; Mayes L; Shukry M; Theroux MC; Watt S; Wong CA
Anesth Analg; 2019 Apr; 128(4):652-659. PubMed ID: 30768455
[TBL] [Abstract][Full Text] [Related]
14. Malignant hyperthermia.
Halliday NJ
J Craniofac Surg; 2003 Sep; 14(5):800-2. PubMed ID: 14501352
[TBL] [Abstract][Full Text] [Related]
15. [S1 guidelines on malignant hyperthermia : Update 2018].
Wappler F
Anaesthesist; 2018 Jul; 67(7):529-532. PubMed ID: 29943228
[TBL] [Abstract][Full Text] [Related]
16. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report.
Friesen CM; Brodsky JB; Dillingham MF
Can Anaesth Soc J; 1979 Jul; 26(4):319-21. PubMed ID: 509349
[TBL] [Abstract][Full Text] [Related]
17. Do we foresee new emerging drugs to treat malignant hyperthermia?
Just KS; Gerbershagen MU; Grensemann J; Wappler F
Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological Treatment of Malignant Hyperthermia: Update 2019].
Schuster F; Johannsen S
Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Sep; 54(9):549-558. PubMed ID: 31525788
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia in the oral and maxillofacial surgery patient: an update.
Patil PM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Sep; 112(3):e1-7. PubMed ID: 21827956
[TBL] [Abstract][Full Text] [Related]
20. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
